Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pravato, Silvia
31  Ergebnisse:
Personensuche X
?
1

Microfluidic Platforms to Screen Granular Hydrogel Microenv..:

Krattiger, Lisa A. ; Emiroglu, Dilara Börte ; Pravato, Silvia...
Advanced Functional Materials.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

Multifocal recurrent neuralgic amyotrophy in an immunocompr..:

Briani, Chiara ; Salvalaggio, Alessandro ; Anglani, Mariagiulia...
Journal of Neurology.  271 (2024)  3 - p. 1080-1083 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against ..:

Angotzi, Francesco ; Petrella, Marco ; Berno, Tamara...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

A Retrospective Study on the Efficacy of Subcutaneous Immun..:

Visentin, Andrea ; Molinari, Maria Chiara ; Pravato, Stefano...
Current Oncology.  30 (2022)  1 - p. 274-283 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Corrigendum to "Venetoclax in combination with hypomethylat..:

De Bellis, Eleonora ; Imbergamo, Silvia ; Candoni, Anna...
Leukemia Research.  115 (2022)  - p. 106811 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Venetoclax in combination with hypomethylating agents in pr..:

De Bellis, Eleonora ; Imbergamo, Silvia ; Candoni, Anna...
Leukemia Research.  114 (2022)  - p. 106803 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-R..:

Frezzato, Federica ; Visentin, Andrea ; Severin, Filippo...
Cancers.  13 (2021)  21 - p. 5453 , 2021
Link: https://doi.org/10.3390/..
 
?
8

Lights and Shade of Next-Generation Pi3k Inhibitors in Chro..:

Visentin, Andrea ; Frezzato, Federica ; Severin, Filippo...
OncoTargets and Therapy.  13 (2020)  - p. 9679-9688 , 2020
Link: https://doi.org/10.2147/..
 
?
9

Ibrutinib in relapsed hairy cell leukemia variant: A case r..:

Visentin, Andrea ; Imbergamo, Silvia ; Trimarco, Valentina...
Hematological Oncology.  38 (2020)  5 - p. 823-826 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Prognostic and Predictive Effect of IGHV Mutational Status ..:

Visentin, Andrea ; Facco, Monica ; Gurrieri, Carmela...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. 678-685.e4 , 2019
Link: https://doi.org/10.1016/..
 
?
11

The combination of complex karyotype subtypes and IGHV muta..:

Visentin, Andrea ; Bonaldi, Laura ; Rigolin, Gian Matteo...
British Journal of Cancer.  121 (2019)  2 - p. 150-156 , 2019
Link: https://doi.org/10.1038/..
 
?
12

Dabigatran in ibrutinib‐treated patients with atrial fibril..:

Visentin, Andrea ; Campello, Elena ; Scomazzon, Edoardo...
Hematological Oncology.  36 (2018)  5 - p. 801-803 , 2018
Link: https://doi.org/10.1002/..
 
?
13

BCR kinase inhibitors, idelalisib and ibrutinib, are active..:

Visentin, Andrea ; Imbergamo, Silvia ; Scomazzon, Edoardo...
British Journal of Haematology.  185 (2018)  1 - p. 193-197 , 2018
Link: https://doi.org/10.1111/..
 
?
14

Role of Rituximab Addition to First-line Chemotherapy Regim..:

Gotti, Manuel ; Sciarra, Roberta ; Pulsoni, Alessandro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079338/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against ..:

Angotzi, Francesco ; Petrella, Marco ; Berno, Tamara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324575/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15